The FDA has concluded its investigation into an outbreak of Salmonella infections related to Rosabella-brand moringa powder capsules distributed by Ambrosia Brands LLC.
As of April 1, there have been 10 patients from eight states confirmed in the outbreak of Salmonella Newport and Salmonella Kentucky. Three of the patients have required hospitalization. The outbreak strains are highly resistant to all first-line and alternative antibiotics commonly recommended for the treatment of Salmonella infections.
 Illnesses started on dates ranging from Sept. 26, 2025, to Jan. 8, 2026. Of the eight people interviewed, seven reported consuming Rosabella-brand moringa powder capsules. There are likely many more sick people associated with this outbreak because for every confirmed patient in a Salmonella outbreak there are 29 who go undetected, according to the Centers for Disease Control and prevention.
As part of the outbreak investigation the Indiana Department of Health collected unopened product samples from a sick person’s home. The sample tested positive for Salmonella Newport and according to whole genome sequencing analysis, it is the same strain of Salmonella Newport causing illnesses in this outbreak.
In response to the investigation, Ambrosia Brands, LLC recalled certain lots of Rosabella-brand moringa powder capsules on Feb.13, 2026. Recalled product was available for sale nationwide and internationally. The product that tested positive for Salmonella was included in the recall. This product should no longer be on the market, but it does have a long shelf life. Retailers and consumers should check for recalled product and throw it away if located.
For a list of the lots recalled in relation to the outbreak, click here.